Dynamic cellemicroenvironment interactions regulate many biological events and play a critical role in tissue regeneration. Cell homing to targeted tissues requires well balanced interactions between cells and adhesion molecules on blood vessel walls. However, many stem cells lack affinity with adhesion molecules. It is challenging and clinically important to engineer these stem cells to modulate their dynamic interactions with blood vessels. In this study, a new chemical strategy was developed to engineer cellemicroenvironment interactions. This method allowed the conjugation of peptides onto stem cell membranes without affecting cell viability, proliferation or multipotency. Mesenchymal stem cells (MSCs) engineered in this manner showed controlled firm adhesion and rolling on E-selectin under physiological shear stresses. For the first time, these biomechanical responses were achieved by tuning the binding kinetics of the peptide-selectin interaction. Rolling of engineered MSCs on E-selectin is mediated by a Ca 2þ independent interaction, a mechanism that differs from the Ca 2þ dependent physiological process. This further illustrates the ability of this approach to manipulate cellemicroenvironment interactions, in particular for the application of delivering cells to targeted tissues. It also provides a new platform to engineer cells with multiple functionalities.
Introduction
Cell membrane engineering (CME) is an emerging research area [1e12] . It refers to the modification of cell membranes with biological, chemical or physical methods to alter cell functions [1e3,6e17] . Engineering cells to present natural or synthetic ligands on their membranes has become a promising modality to control cellemicroenvironment interactions that are crucial in tissue regeneration. One potential application of CME is to navigate cells, such as stem cells, to targeted tissues [2, 10] . Stem cells hold great promise for regenerative medicine. However, one of the major obstacles of stem cell-based therapy is the homing and retention of cells in tissues requiring regeneration [18, 19] . One goal of CME is to modify human bone marrow-derived mesenchymal stem cells (hMSCs) to target receptors expressed on inflamed vessels of injured tissues. A natural response to injury is inflammation, during which certain circulating cells are recruited. Inflammatory cytokine-activated endothelial cells express adhesion molecules, Eand P-selectins to induce the rolling of leukocytes in postcapillary venules in the presence of Ca 2þ , as well as vascular cell adhesion molecule 1 to mediate the firm adhesion of leukocytes [20] . For leukocytes and other cells to tether and roll on inflamed vessels, specific receptors on their membranes must be glycosylated with sialyl Lewis X (sLex), a tetrasaccharide [21e23]. hMSCs do not express receptors binding to E or P-selectin after they have been expanded ex vivo, due to the lack of sLex. In a previous report, sLex was generated on the membranes of hMSCs by a-1,3-fucosyltransferase, which allowed hMSCs to target the bone marrow of mice after intravenous administration [2] . However, this method requires a specific enzyme to generate one particular function, limiting its potential applications. In another report, sLex was anchored on the membranes of hMSCs via streptavidin-biotin bridges, which also resulted in cell rolling [10] . However, methods with less steps and that avoid the use of streptavidin, which may be immunogenic, would be favored for clinical applications [24] . Ligands with lipid or alkyl chains can be anchored on cell surfaces by inserting hydrophobic tails into lipid bilayer of cells [5] . This approach, though convenient, is less suitable for applications that exert strong forces on the ligands. This is due to the weak interaction between hydrophobic tails and membrane lipids, particularly in serum [25] . This problem can be reduced by using ligands containing multiple hydrophobic tails [15, 16] .
Herein, we present a new facile chemical method to conjugate synthetic ligands on cell membranes to control cellemicroenvironment interactions, in particular the binding of stem cells on adhesion molecules. This strategy overcomes the limitations of previous approaches. It is general and suitable for manipulating cellecell and cell-matrix surface interactions with controlled binding dynamics and kinetics. Cell rolling is a mechanically delicate process with well balanced dynamics of bond formation and breakage, which requires proper binding kinetics between adhesion molecules and ligands on cell membranes. We engineered hMSCs to firmly adhere or roll under physiologically relevant shear stresses by tuning the kinetics of the interaction between peptides and selectins. This interaction is artificial and is Ca 2þ independent. In this study, mouse MSCs (mMSCs) were also engineered to roll. The comparison of engineered hMSCs and mMSCs revealed that the size of cells is an important parameter to consider when engineering cells in this manner. 
Materials and methods

Materials
Coating microfluidic devices
Microfluidic devices were fabricated by rapid prototyping in polydimethylsiloxane (PDMS) using SU-8 photoresist masters [26] . Autoclave-sterilized PDMS microfluidic devices were washed 3 times with phosphate buffered saline (PBS). The interior of the microfluidic channels was coated with recombinant human E-selectin/CD62E/Fc chimera by filling the channels with indicated concentrations of E-selectin-PBS solution and incubating for 4 h at 37 C, followed by incubation in 1% BSA-PBS blocking solution for 30 min. Recombinant human IgG 1 FC at 5 mg/mL instead of E-selectin was used to coat microfluidic channels in one control experiment. Devices were washed 3 times with PBS before use.
Cell culture and chemical modification of cell membranes
hMSCs were cultured at 37 C/5% CO 2 in mesenchymal stem cell growth medium. hMSCs expressing GFP and hMSCs expressing mCherry were generated by infecting cells with hPGK-eGFP lentivirus and hPGK-mCherry lentivirus respectively. The titer of virus was 5 Â 10 7 TU/mL. To infect cells, 5 mL of viral vector solution was used per 20,000 hMSCs in one well of a 6-well plate. The medium was replaced with fresh medium after 24 h.
To chemically modify the cell membranes, MSCs were cultured in a flask until the confluency reached w70%. Cells were rinsed 3 times with PBS and then incubated with 100 mM NHS-PEG 2 -maleimide for 15 min at room temperature. After the first step of membrane modification, cells were rinsed 3 times with PBS to wash away the unreacted reagent. Cells were further treated with peptide ligands by incubating them in a solution of 6 mM peptides for 15 min at room temperature. Prior to use, peptides were reduced with immobilized TCEP disulfide reducing resin for 2 h. After conjugating the peptide ligands onto cell membranes, cells were trypsinized for further testing.
To measure the density of peptides on cell membranes, 5-FAM-peptide (Nterminal modification) was used for cell membrane modification. The concentration-fluorescence intensity working line was generated by using the peptide at concentrations ranging from 0.049 mM to 1.25 mM. The fluorescence intensity of 10 5 engineered hMSCs was measured at the same time on a plate reader (PerkinElmer 1420 Multilabel Counter). The intensity of unmodified cells as the control was found negligible. Cells were also imaged with a laser scanning confocal microscope (Zeiss LSM 510) to determine peptide distribution on cell membranes. Z stack images were reconstructed by Zen 2009 light edition software. HL-60s were cultured at 37 C/5% CO 2 in Iscove's Modified Dulbecco's Medium supplemented with 20% FBS. mMSCs were cultured at 37 C/5% CO 2 in MEM alpha medium supplemented with 10% FBS.
Stem cell proliferation and differentiation
The viability of cells was tested by trypan blue. To test cell proliferation, the unmodified hMSCs and hMSCs conjugated with peptides on membranes were placed in a 96-well plate at 4000 cells/well. At 1, 4 and 7 d following seeding, the mesenchymal stem cell growth medium was replaced with phenol red free DMEM medium supplemented with 10% FBS, and the AlamarBlue assay was performed. The AlamarBlue reagent was added to each well according to the manufacturer's instructions and incubated for 90 min. The supernatant from each well was transferred to a black 96-well plate and the fluorescence intensity was measured on a plate reader.
To test hMSCs differentiation, 5 Â 10 4 cells/well and 1.5 Â 10 4 cells/well were seeded in 12-well plates for adipogenesis and osteogenesis respectively. After 24 h, growth medium was replaced with osteogenic differentiation medium for osteogenesis, while cells for adipogenesis were allowed to grow in growth medium for 3 d to reach >95% confluency before replacing the medium with adipogenic differentiation medium. Fresh differentiation medium was added to cells every 3 d. At the 24th day after cell seeding, all cells were fixed with Formalin free fixative at room temperature for 20 min. Oil red O was used to probe cells under adipogenesis and control cells growing in regular growth medium. 6 mL Oil red O in isopropanol was mixed with 4 mL ddH 2 O and filtered by 0.2 mm pore size membrane after staying at room temperature for 10 min. Oil red O in working solution was added to each well at 0.6 mL. The cells were washed with PBS after 20 min and imaged using phasecontrast model of a microscope (Zeiss Axiovert). To probe alkaline phosphatase activity of osteogenic cells, Fast Blue RR Salt capsule was dissolved in 48 mL ddH 2 O with 2 mL Naphthol AS-MX phosphate alkaline solution. Fixed cells were carefully washed with ddH 2 O before and after applying probing solutions. Cells were imaged at a brightfield model. To quantify the stem cell differentiation, mRNA marker expression was analyzed by real time PCR. Total RNA was isolated from cells using the TRIzol method. Total mRMA (0.5 mg) was reverse-transcribed using SuperScript reverse transcriptase with random hexamer. Quantitative PCR was performed using Taqman Fast Universal PCR Master Mix on a StepOnePlusTM Rreal-Time PCR System. Osteogenic differentiation was examined using Taqman Gene Expression Assays including OCN (Hs00754870_s1) and Runx2 (Hs00231692_m1). Adipogenic differentiation was examined using PPARG (Hs01115512_m1) and GTF3A (Hs01047486_g1). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Hs99999905_m1) was used as a reference control. The level of expression of each target gene was then calculated as 2
ÀDDCt .
Flow channel adhesion assay
The binding capacities of chemically engineered cells and unmodified cells to Eselectin were evaluated in microfluidic channels mimicking some aspects of the flow conditions in inflammatory blood vessels. To facilitate comparison, GFP-hMSCs modified with peptide K were mixed with unmodified mCherry-hMSCs at the same cell density. The mixed cells were injected into microfluidic channels coated with E-selectin or with human IgG 1 FC as a control. The cells were allowed to attach to the substrates for 2 min before initializing the flow of pre-warmed medium through the channels. The flow speed was controlled by a syringe pump (Harvard Apparatus PHD 2000), and the shear stress was calculated based on the channel size according to a reference [27] . Cells in the channels were monitored and recorded under flow conditions by time-lapse imaging (total time ¼ 2 min; interval ¼ 1 s) with a fluorescent microscope (Zeiss Axiovert). Experiments were repeated 3 times under each fluid shear stress. For cell rolling experiment, the membranes of cells were conjugated with peptide M. The cells were allowed to attach to the substrates for 2 min before initializing the flow. For shear stress >1.25 dyn/cm 2 , cells were first exposed under flow with shear stress 1.25 dyn/cm 2 for 30 s before applying the targeted shear stresses. Cells in the channels were monitored and recorded under flow conditions by time-lapse imaging. The rolling distances were measured by ImagJ, and the rolling velocities were calculated with the information of time. At each shear stress, 15 cells with rolling time longer than 30 s were randomly selected for calculations.
Measurement of binding kinetics of peptides and E-selectin
The binding kinetics of the two peptides to E-selectin was determined by surface plasmon resonance (SPR) using a Biacore T100 instrument via capture approach. Briefly, anti-human IgG Fc monoclonal antibody was immobilized to the flow cell (Fc) 1 and 2 of a CM5 Sensorchip via amine coupling per the manufacturer instructions. For each cycle, the recombinant human E-selectin protein (20 mg/mL) was captured onto the Fc2 to approximately 1300 response units (RU), followed by the injection of peptides (Peptide K and Peptide M) over both flow cells at 100 mL/ min for 120 s and a dissociation phase of 300 s. Regeneration of the surface was achieved via injection of 3M magnesium chloride at 10 mL/min for 30 s. A concentration series (10, 3.33, 1.11, 0.37, 0.12, 0.04, 0.013 and 0 mM, in HBS-EPþ with 0.2% DMSO) of each peptides were used. The peptides were not modified at the Nterminus with CGS to prevent the formation of peptide dimer and the potential interaction between thiol group and the chip surface. The 1X HBS-EPþ was used as the running and sample dilution buffer. The resulted sensorgram were analyzed with Biacore T100 Evaluation software v1.1.1. The results were double referenced, the association, dissociation and steady state dissociation constant were determined with 1:1 binding curve fitting as well as steady state affinity analysis.
Measurement of cell tethering
Microfluidic channels were coated with 5 mg/mL E-selectin for cell tethering experiment. HL-60s and hMSCs and mMSCs engineered with peptide K were flushed into the microfluidic devices individually at a concentration 500,000 cells/mL. Cells were monitored and recorded under flow conditions by time-lapse imaging (total time ¼ 2 min; interval ¼ 2 s) with a fluorescent microscope (Zeiss Axiovert) at a phase-contrast model. The experiments were repeated a few times to find the maximum flow velocity, that cells could still attach to substrates.
Results and discussion
To engineer the membranes of hMSCs to present synthetic peptides, a linker molecule, NHS-PEG 2 -maleimide, was first reacted with amine groups on membrane proteins (Fig. 1) . Then peptides containing a thiol on the N-terminus were anchored on the membranes by reacting with maleimide on the linker. For this study, a known E-selectin strong binding peptide [28] was modified with glycineeserine as a flexible linker and a cysteine providing the thiol group, H 2 N-CGSDITWDQLWDLMK-COOH (peptide K). The number of synthetic ligands on engineered cells was determined by using a fluorescently labeled 5-FAM-peptide K, and measuring the fluorescence intensity of engineered cells. There was an average of 1.5 Â 10 7 peptides per cell when hMSCs were modified using 100 mM NHS-PEG 2 -maleimide and 6 mM peptide. Cells were modified at this condition in all experiments unless otherwise specified. When the concentration of NHS-PEG 2 -maleimide was increased to 800 mM, the average number of peptides per cell increased to 9 Â 10 molecules during the CME process. Cells were attached on a tissue culture-treated substrate during modification. This is a rapid procedure with membrane engineering taking only 30 min to complete. After the cells were detached, the ligands were distributed on the cells relatively uniformly (Fig. 2a, Supplementary Mov. 1), even though it is possible that the chemical reactions occurred only on a portion of the membranes exposed to solution. This distribution is different from our reported asymmetrical distribution of nanoparticles on cell membranes [11] . In contrast to nanoparticles that can bind to several receptors on a membrane, each peptide only binds to one receptor, allowing diffusion on semi-fluid cell membranes. When engineered cells were suspended in medium at 37 C after surface modification, most peptides stayed on cell membranes without being internalized for at least 6 h ( Supplementary Fig. 1 ). The viability of hMSCs after modification was >95%, similar to untreated cells. There was no difference in cell proliferation rates between engineered cells and untreated cells at day 4 or day 7 after treatment ( Supplementary Fig. 2 ). However when peptides were conjugated on hMSCs at a high concentration of 9 Â 10 7 /cell, the cells could not reattach to the tissue culture-treated substrates, even though the cells were viable. It is possible that the chemically conjugated peptides block the interactions between cell adhesion molecules and proteins adsorbed on substrates at this high peptide density. The multipotency of stem cells is critical for their regenerative ability. To evaluate the multipotency, the ability of engineered hMSCs to differentiate into adipocytes and osteogenic cells was analyzed and compared to those of unmodified cells (Fig. 2b,c) . Cells were allowed to grow in adipogenic differentiation medium, osteogenic differentiation medium, or standard hMSC growth medium for three weeks. Differentiated adipocytes from engineered and unmodified hMSCs showed a bright red color when stained with oil red O, which stains fat globules (Fig. 2b) . The alkaline phosphatase activity of cells increased after osteogenesis, indicated by the purple-blue color of histochemically stained cells. Cells that grew in growth medium did not show staining for either adipogenesis or osteogenesis. The differentiations of hMSCs were further quantified by RT-PCR analysis of RNA markers (Fig. 2c) . The mRNAs of PPARg and GTF3A were quantified for adipogenesis, while those of Runx2 and OSCN were quantified for osteogenesis. Engineered hMSCs retained their multipotency under the appropriate conditions. To determine if the membrane-engineered hMSCs have the potential to target and remain in regions presenting E-selectin, we used polydimethylsiloxane (PDMS) microfluidic devices as an in vitro model of inflamed blood vessels (Fig. 3) . The cross-section of the microfluidic channel was 1250 Â 450 mm. The internal surface of the channels was coated with recombinant human E-selectin. The ability of cells to bind to the E-selectin surface was tested simultaneously for hMSCs presenting peptide K and for unmodified hMSCs. To facilitate visualization and distinction between these two groups of cells in the devices, the cells were transduced to internally express fluorescent proteins. Peptide K-modified hMSCs expressed green fluorescent protein, GFP (GFP-hMSCs), while unmodified hMSCs expressed red fluorescent protein, mCherry (mCherry-hMSCs). The cells were mixed together, and injected into the devices. Fluid shear stresses in channels were controlled by changing the flow rate of the growth media through the devices. Cells under shear stresses were visualized and recorded (Representative movies at each shear stress are available in Supplementary Mov. 2). Only membrane-engineered hMSCs were bound under flow (Fig. 3) . As the shear stress was increased, more engineered cells were flushed away. Physiologically, leukocytes tether and roll in postcapillary venules, where the shear stress is 1e4 dyn/ cm 2 [29] . More than 80% of the membrane-engineered hMSCs were Supplementary data related to this article can be found online at doi:10.1016/j.biomaterials.2012.03.065.
Retention on inflamed vessels is an important step for cells to home to targeted tissues, and it requires firm adhesion. However, cell rolling is a dynamic process of the formation of new bonds and dissociation of existing bonds between cells and vascular adhesion molecules. The rate constants of peptide-selectin bond formation (k on ) and dissociation (k off ) are kinetic parameters governing the interaction of engineered cells and selectins. According to the Bell model, k off ¼ k off o exp(gF/nk B T), where k off o is the k off at zero pulling force, g is the bond interaction range, F is the flow force on a cell, n is the number of bonds under force and k B T is the thermal energy [31] . In order for cells to roll, fast k off and k on are needed so that the existing bonds break at the trailing edge, allowing cells to move, while at the same time, new bonds can create at the leading edge [32e34]. Additionally, although Ca 2þ independent cell rolling on other biomolecules has been studied [32, 35] , previously described mechanisms for cell rolling on E-selectin are Ca 2þ dependent
[21e23], but peptide K is known to bind to E-selectin through a Ca 2þ independent mechanism [28] . We asked if the artificial interaction could be tuned to assist engineered cells to roll under physiologically relevant shear stresses. To this end, we removed Lysine from the C-terminus of the peptide K to give the sequence CGSDITWDQLWDLM (peptide M), which was reported to have a moderate binding IC50 with E-selectin [28] . We employed surface plasmon resonance to detect binding kinetics and dissociation constants of peptides. The SPR sensorgrams of binding curves of peptides on immobilized E-selectin were shown in Fig. 4 . The k off of peptide M is 10 times faster than that of peptide K at a compensation of 54% decrease of k on (Table 1) . When hMSCs displaying peptide M were placed in the microfluidic channels coated with E-selectin, the cells rolled under physiological shear stresses (Fig. 5a ). The average rolling velocity was substantially lower than the fluid velocity. For example, the average medium flow speed at shear stress 10 dyn/cm 2 was 11.9 cm/s, while the average cell rolling velocity was 0.8 mm/s and 1.8 mm/s for surfaces coated with 5 mg/mL and 2 mg/mL E-selectin (Fig. 5b) . The potential for cells to roll on E-selectin substrates depend on surface density of E-selectin and the size of cells. A leukemia cell line, HL-60 is known to express selectin natural ligand, PSGL-1 [36] , and was used as a control in our experiment.
HL-60s showed stable rolling on 0.1 mg/mL and 0.5 mg/mL E-selectin coated surfaces (Fig. 5c) leukocytes and blood cells promote cell tethering [40] . Our model does not mimic these conditions, and cells have less chance to contact the substrate to initiate binding. By flushing cells directly into microfluidic channels without stopping flow, we have found cells effectively tethered on substrates coated with 5 mg/mL Eselectin at shear stress 0.5 dyn/cm 2 , 0.25 dyn/cm 2 and 0.2 dyn/cm 2 for HL-60s, peptide K-mMSCs and peptide K-hMSCs respectively (Fig. 6 ). HL-60s were more efficient than stem cells that were engineered with peptide K in tethering. A major advance of the CME strategy presented here is that the binding kinetics of cells can be controlled for the desired application. The rolling of engineered stem cells in vivo will be investigated in the future and optimized for targeted tissues by tailoring the binding of peptides to selectins. The reaction of NHS-PEG 2 -maleimide with cell membranes has less specificity than enzymatic coupling. This provides versatility, but may not be beneficial for all applications. The enzymatic approach also introduces less immunogenic epitopes and may have lower barrier for clinical trials. In the future, bioorthogonal and site specific chemistry on cell surfaces [41] may be necessary to apply membrane-engineered stem cells to clinical applications. Future work aimed at testing if engineered stem cells are capable of extravasation into injured tissues will also be highly valuable. Another interesting aspect of this approach is that the rolling of engineered cells on E-selectin is Ca 2þ independent. This further illustrates the ability of this approach to manipulate cellemicroenvironment interactions in the context of regenerative medicine.
Conclusions
We have developed a chemical method to conjugate synthetic ligands on stem cell membranes to control cellemicroenvironment interactions. This approach does not affect cell viability, proliferation or multipotency. It is convenient, robust, inexpensive and complementary to other CME strategies, providing broad application potentials. We showed that, at proper binding kinetics and dynamics, rolling of engineered cells under physiologically relevant shear stresses could be realized via an artificial interaction between membrane conjugated peptides and E-selectins. Theoretical models of cell rolling focused on the molecular interactions and the fluid mechanics. But knowledge in this aspect has only been used to explain phenomena of natural cell rolling and rolling of beads, and had not been used to design engineered cells. Our work validated these theoretical studies and will allow refined theoretical models to be developed to guide the design of better engineered cells. Our cell engineering strategy has the potential to render cells with the ability to target any receptors with controlled binding affinity and kinetics. This technique may be applicable for navigating dendritic cells to lymph nodes and in the therapy of inflammation-associated diseases, such as myocardial infarction, atherosclerosis and cancer. In addition to cell targeting, our chemical approach may also be useful to engineer cells with multiple functionalities, such as cell labeling and sensing. Fig. 6 . Tethering of membrane-engineered stem cells and HL-60s on E-selectin coated substrate at different time points. hMSCs and mMSCs were modified at 100 mM NHS-PEG 2 -maleimide and 6 mM peptide K. After trypsinization and resuspension in medium, cells at 500,000 cells/mL were flushed into microfluidic devices that were coated with 5 mg/mL Eselectin before use. Images were taken at shear stress 0.2 dyn/cm 2 , 0.5 dyn/cm 2 and 0.25 dyn/cm 2 for hMSCs, HL-60s and mMSCs respectively. Black arrows mark some of the tethered cells.
